[144] NOVA LTD. SEC Filing

Rhea-AI Filing Summary

NOVA Ltd. (NVMI) Form 144 summary: An individual proposes to sell 852 ordinary shares through Oppenheimer & Co. on Nasdaq, with an aggregate market value of $263,770.68. The issuer shows 29,278,401 shares outstanding. The 852 shares were acquired as Restricted Stock Units (RSUs) on 05/18/2023 and were paid/issued on that date. The filer also reported multiple ordinary-share sales by the same person during the past three months: 135, 720, 1,390, and 479 shares on specified dates, with listed gross proceeds. The notice includes the standard attestation that the seller is not aware of undisclosed material adverse information.

Positive

• Transparent disclosure of the proposed sale including broker, share count, and aggregate market value
• Acquisition details are provided showing the shares originated from RSUs granted on 05/18/2023
• Recent sales history for the seller is disclosed with dates and gross proceeds, aiding market transparency

Negative

• Insider selling activity — multiple sales in the past three months (totaling 2,724 shares) may be viewed negatively by some investors
• Concentration risk not addressed — filing does not state the seller's remaining holdings, so relative impact on ownership is unclear

Insights

Securities Analyst

TL;DR: This Form 144 discloses a routine proposed sale of 852 RSU-derived shares and prior small sales by the same individual; context suggests routine insider liquidity.

The filing documents a proposed sale of 852 ordinary shares valued at $263,770.68 to be executed via Oppenheimer & Co. The shares were issued as RSUs on 05/18/2023. The filer also reported four sales in the prior three months totaling 2,724 shares with disclosed gross proceeds for each transaction. For investors, this is a factual disclosure of intended insider selling; the amounts disclosed represent a small fraction of the 29,278,401 shares outstanding and do not by themselves indicate company-level financial change.

Compliance / Risk Analyst

TL;DR: The Form 144 appears complete for Rule 144 purposes, listing acquisition details and recent sales; it contains the required seller attestation.

The document specifies the nature of acquisition (Restricted Stock Units), acquisition and payment dates, broker information, and past sales with gross proceeds. It includes the mandatory representation about material non-public information and the signature attestation language. From a compliance perspective, the filing provides the necessary elements to support a Rule 144 sale; additional documents (e.g., executed trading plan) are not indicated in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc 85 Broad St. New York NY 10004	852	263770.68	29278401	09/22/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	05/18/2023	Restricted Stock Units	Issuer			852	05/18/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Simon Zehava 5 DAVID FIKES STREET Rehovot L3 7610201	Ordinary	06/24/2025	135	32400.00
Simon Zehava 5 DAVID FIKES STREET Rehovot L3 7610201	Ordinary	06/26/2025	720	188640.00
Simon Zehava 5 DAVID FIKES STREET Rehovot L3 7610201	Ordinary	06/30/2025	1390	391980.00
Simon Zehava 5 DAVID FIKES STREET Rehovot L3 7610201	Ordinary	09/15/2025	479	143221.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the NVMI Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 852 ordinary shares via Oppenheimer & Co. on Nasdaq with an aggregate market value of $263,770.68.

When and how were the 852 shares acquired?

The 852 shares were acquired as Restricted Stock Units (RSUs) on 05/18/2023 and were paid/issued on that date.

Has the seller sold other NVMI shares recently?

Yes. The seller reported four sales in the past three months: 135 shares on 06/24/2025, 720 on 06/26/2025, 1,390 on 06/30/2025, and 479 on 09/15/2025, with listed gross proceeds for each.

How many NVMI shares are outstanding according to the filing?

The filing reports 29,278,401 shares outstanding.

Does the filing state whether the seller knows any material non-public information?

Yes. The seller attests by signature that they do not know any material adverse information about the issuer that has not been publicly disclosed.